Iridex (IRIX) Acquisitions (2011 - 2022)

Iridex (IRIX) recorded quarterly Acquisitions of -$5.3 million in Q4 2022, down 200.0% quarter-over-quarter from $5.3 million in Q2 2021.

Iridex (IRIX) Acquisitions (2011 - 2022) Analysis & Trends

Iridex's Acquisitions history runs 3 years deep, the most recent figure standing at -$5.3 million for Q4 2022.

In Q4 2022, Acquisitions changed N/A year-over-year to -$5.3 million; the TTM figure through Oct 2021 stood at $5.3 million (changed N/A YoY), while the FY2022 annual figure was $5.3 million, changed N/A from the prior year.
Acquisitions was -$5.3 million for Q4 2022 at Iridex, down from $5.3 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $5.3 million in Q2 2021 to a low of -$5.3 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-268.10 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.30 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Iridex	19.91 Mn	15.31 Mn	4.74 Mn	-

Download Data